Alterity Therapeutics Limited (NASDAQ: ATHE)
$2.1600
+0.0600 ( +4.85% ) 18.8K
Alterity Therapeutics Ltd is active in the healthcare domain. The company is engaged in research collaborations for the treatment of Parkinsonian movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders. The company's lead drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has also advanced a drug candidate for Parkinson's disease and other movement disorders (ATH434). The Group operated in one segment, being researching and developing Parkinsonian and other neurodegenerative disorders.
Market Data
Open
$2.1600
Previous close
$2.1000
Volume
18.8K
Market cap
$18.36M
Day range
$2.0300 - $2.2200
52 week range
$1.0010 - $3.1900
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
6-k | Form 6-K | 3 | Jan 11, 2024 |
6-k | Form 6-K | 3 | Jan 11, 2024 |
6-k | Form 6-K | 3 | Jan 10, 2024 |
6-k | Form 6-K | 4 | Jan 08, 2024 |
6-k | Form 6-K | 3 | Jan 08, 2024 |
6-k | Form 6-K | 3 | Jan 08, 2024 |
6-k | Form 6-K | 4 | Jan 08, 2024 |
6-k | Form 6-K | 4 | Jan 05, 2024 |
6-k | Form 6-K | 4 | Jan 05, 2024 |
6-k | Form 6-K | 3 | Jan 02, 2024 |